- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
This is a Virtual Event for PsychU members in Delaware, Maryland, New Jersey, Pennsylvania, and West Virginia.
This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of prevalence and challenges in diagnosis and explore the potential pathobiological correlations in AAD. Describes the clinical and humanistic burden and discusses current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease. It underlines unmet needs for FDA-approved pharmaceutical treatments for agitation to improve care and quality of life for patients suffering from AAD.
Featuring
E. Jeffrey Greenberg, MD
Neurologist at Princeton & Rutgers Neurology, P.A., Co-Founder of Advanced Clinical Institute
MoreDr. Jeffrey Greenberg, a native of Philadelphia, joined Princeton & Rutgers Neurology in 2003. He received his Bachelor’s degree in English from Cornell University and his medical degree from Drexel University, College of Medicine. He completed his Neurology residency at the Albert Einstein College of Medicine in New York, serving as Chief Resident in his final year. He subsequently completed an EMG/Neuromuscular fellowship at Albert Einstein. He is Board Certified in Neurology by the American Board of Psychiatry and Neurology and also Board Certified by the American Associate of Neuromuscular and Electrodiagnostic Medicine. Dr. Greenberg now focuses his practice on Parkinson’s Disease, Dementia, Multiple Sclerosis, and Neuromuscular Disease. Additionally, he has experience as a Principle Investigator for Alzheimer’s disease clinical trials and remains involved in the field.
Becky Wong, PharmD, MBA
Medical Science Director
Speaker E. Jeffrey Greenberg, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Becky Wong, PharmD, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Related Events
-
Virtual Event – Addressing Unresolved Symptoms of Major Depressive Disorder
December 5 12:00 pm to 1:00 pm -
Virtual Event – Unmet Needs in Agitation Associated with Dementia Due to Alzheimer’s Disease
December 10 3:00 pm to 4:00 pm -
Virtual Event – Strategies to Optimize Patient Outcomes in Bipolar I Disorder
December 11 1:00 pm to 3:00 pm
Registration
Related Resources
-
Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)
On-Demand Webinar December 3, 2025In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.
-
Myths & Misconceptions: Bipolar Disorder
Podcast November 10, 2025Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.
-
Understanding the Complexity of Attention-Deficit Hyperactivity Disorder
On-Demand Webinar October 16, 2025Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected:


